Familial Atypical Multiple Mole Melanoma SyndromeSymptoms, Doctors, Treatments, Advances & More
Learn About Familial Atypical Multiple Mole Melanoma Syndrome
Pedram Gerami is a Dermatologist practicing medicine in Chicago, Illinois. Dr. Gerami is rated as an Elite provider by MediFind in the treatment of Familial Atypical Multiple Mole Melanoma Syndrome. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Melanoma, Familial Atypical Multiple Mole Melanoma Syndrome, Tieche-Jadassohn Nevus, and Giant Congenital Melanocytic Nevus. Dr. Gerami is board certified in American Board Of Dermatology - Dermatology (Certified). Dr. Gerami is currently accepting new patients.
Avera Dermatology — Pierre
J Fletcher is a Dermatologist practicing medicine in Pierre, South Dakota. Dr. Fletcher is rated as a Distinguished provider by MediFind in the treatment of Familial Atypical Multiple Mole Melanoma Syndrome. She is also highly rated in 35 other conditions, according to our data. Her clinical expertise encompasses Giant Congenital Melanocytic Nevus, Familial Atypical Multiple Mole Melanoma Syndrome, Giant Congenital Nevus, and Neurocutaneous Melanosis. Dr. Fletcher is currently accepting new patients.
Newton Wellesley Dermatology Associates
Caroline Kim is a Dermatologist practicing medicine in Wellesley, Massachusetts. Dr. Kim is rated as an Elite provider by MediFind in the treatment of Familial Atypical Multiple Mole Melanoma Syndrome. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Familial Atypical Multiple Mole Melanoma Syndrome, Melanoma, Giant Congenital Melanocytic Nevus, and Giant Congenital Nevus. Dr. Kim is currently accepting new patients.
Summary: This study will investigate how genetic and environmental factors contribute to the development of melanoma, a type of skin cancer, and related conditions. Individuals \>=4 weeks with a personal or family history of melanoma or atypical spitzoid/Spitz tumor may be eligible for this study. Participants will: * Fill out one or two questionnaires about their personal and family medical history. * Pro...
Summary: Johns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins. The Sub Investigator at each site will be responsible for internal monitoring at their site.
Published Date: May 10, 2022
Published By: Genetic and Rare Diseases Informnation Center